Jobs
Required skills
Bosnian
English
Translation
Life Sciences Content
CAT Tools
Are you a freelance translator with a passion for life sciences content? Join us on an exciting journey and become a member of our growing global community of linguists. The IQVIA Translation Services team is looking for freelance translators from Bosnian into English. You will work with a truly global industry leader to deliver content in our target languages and markets in the most effective and timely fashion.
For qualified and interested candidates permanent positions may be considered as well.
In order to be considered you need to meet the below criteria:
Native fluency in target language – spoken and written
Fluency in source language(s) – spoken and written
At least 1 year of experience translating, reviewing and editing life sciences content including clinical trial documents. Must be clearly outlined in your CV with document types.
A university degree in translation or linguistics and at least 2 years of translation experience OR no university degree and at least 5 years of translation experience
Be able to work according to tight deadlines and independently is a must
Experience with translation management systems and CAT tools is a must
Prior experience as a translator with a translation and localisation company is desirable, yet not essential
All locations will be considered
If you are interested in joining us, please submit your application in English and include your rates in your application.
We will not accept applications from Agencies. If you represent an agency or team of linguists, PLEASE DO NOT APPLY. This posting is for individual freelancers only.
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. We believe in pushing the boundaries of human science and data science to make the biggest impact possible – to help our customers create a healthier world. Learn more at https://jobs.iqvia.com
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. We believe in pushing the boundaries of human science and data science to make the biggest impact possible – to help our customers create a healthier world. Learn more at https://jobs.iqvia.com
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs

Corporate Banking - Innovation Economy Analyst
JPMorgan Chase · Sydney, NSW, Australia, AU

L2 Systems Analyst, SaaS Operations, Officer
State Street · Melbourne, Australia

Electrolyzer Service Specialist
Plug Power · Remote Australia

OCM Consultant
Leidos · 3 Locations

Storeperson Resourcing Centre
DHL · South Australia, Australia
About IQVIA

IQVIA
PublicIQVIA Holdings, Inc. is an American company based in Durham, North Carolina, focused on health information technology and clinical research.
10,001+
Employees
Durham
Headquarters
$17B
Valuation
Reviews
3.6
10 reviews
Work-life balance
3.8
Compensation
2.5
Culture
4.0
Career
3.2
Management
2.8
65%
Recommend to a friend
Pros
Good work-life balance
Supportive team and collaborative environment
Good benefits and flexible hours
Cons
Compensation below industry standards
High workload and overwhelming at times
Management communication and organization issues
Salary Ranges
45 data points
Mid/L4
Director
Mid/L4 · CLIENT OPERATIONS LEAD
2 reports
$114,000
total per year
Base
$91,012
Stock
-
Bonus
-
$114,000
$114,000
Interview experience
3 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Experience
Positive 0%
Neutral 33%
Negative 67%
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Technical Manager Interview
5
Executive/GM Interview
6
Offer
Common questions
Behavioral/STAR
Case Study
Technical Knowledge
Past Experience
Culture Fit
News & Buzz
IQVIA Shareholders Approve New 2026 Incentive Plan - TipRanks
TipRanks
News
·
2d ago
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
MarketWatch
News
·
3d ago
The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares - Fierce Pharma
Fierce Pharma
News
·
3d ago
The outlook for obesity from 2026 to 2030 - IQVIA
IQVIA
News
·
5d ago